GSK plc ADR buy Citigroup Inc.
Start price
26.06.24
/
50%
€36.40
Target price
26.06.25
-
Performance (%)
-10.44%
End price
27.06.25
€32.60
Summary
This prediction ended on 27.06.25 with a price of €32.60. The prediction for GSK plc ADR disappointed with a performance of -10.44%. Dividends of €1.10 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | -1.923% | -1.923% | 24.390% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Citigroup_Inc_ for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten